-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Gene Editing for Fanconi Anemia Bone Marrow Failure

Program: Scientific Program
Session: JOINT SESSION: Therapeutic Gene Editing of Stem Cells in Classical and Malignant Hematology
Sunday, December 8, 2024, 9:30 AM-11:05 AM

Paula Rio, PhD

IIS-FJD, UAM, Madrid, Spain; CIBERER, MADRID, Spain; CIEMAT, Madrid, Spain

Disclosures: Rio: Rocket Pharmaceuticals: Current equity holder in publicly-traded company, Honoraria, Patents & Royalties, Research Funding.

See more of: JOINT SESSION: Therapeutic Gene Editing of Stem Cells in Classical and Malignant Hematology
See more of: Scientific Program
<< Previous Presentation | Next Presentation >>